Summary & Overview
HCPCS J0133: Injection, Acyclovir 5 mg
HCPCS Level II code J0133 denotes an injection of acyclovir, 5 mg, used to bill for the drug component of antiviral therapy in outpatient and acute care settings. This code matters nationally because acyclovir injections are used for treatment of serious herpesvirus infections and represent a discrete billable drug unit that affects facility and professional reimbursement, supply management, and utilization tracking.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of billing implications, common billing modifiers, and the clinical context for use of injectable acyclovir. The publication outlines typical service settings where J0133 is billed and highlights policy considerations that influence coverage and prior authorization requirements.
The report provides benchmarks for unitization and billing frequency where available, summarizes payer coverage tendencies, and explains coding nuances relevant to pharmacy and infusion service lines. Data not available in the input is noted where applicable. The content is intended to inform billing staff, pharmacy managers, and policy analysts about the operational and coding aspects of HCPCS Level II code J0133.
Billing Code Overview
HCPCS Level II code J0133 represents an injection of acyclovir, 5 mg. This code describes the drug product and the unit of service for billing purposes.
Service Type: Drug administration / injectable antiviral therapy
Typical Site of Service: Outpatient infusion or injection settings, clinic, or emergency department
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an outpatient infusion center or emergency department with an acute severe herpesvirus infection (for example, disseminated herpes simplex virus or severe varicella-zoster in an immunocompromised patient) requiring intravenous antiviral therapy. The treating clinician (infectious disease specialist, emergency physician, hospitalist, or oncology/hematology team) orders IV acyclovir dosed by weight. Pharmacy compounds the supply using J0133 billed per 5 mg unit and prepares the infusion or bolus. Nursing documents medication administration, vital signs, infusion reaction monitoring, and renal function assessments before and during therapy due to acyclovir’s nephrotoxicity risk. Typical workflow steps: clinician order → pharmacy verification and dose calculation → IV preparation and labeling → bedside administration with appropriate modifier usage for billing (for example, outpatient service, emergency department service, or modifier to indicate drug wastage) → documentation of indication, dose, lot number, and patient response in the medical record.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
JW | Drug discarded/unused amount | When part of a single-dose vial is discarded and payer permits reporting discarded drug separately. |